B.A.D. ETF (BAD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
B.A.D. ETF (BAD) trades at $11.91 with AI Score 44/100 (Grade C). B. A. D. Market cap: $9.53M, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for BAD: BAD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BAD against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BAD: the 1 perspectives are evenly split.
How is this calculated? →B.A.D. ETF (BAD) Financial Services Profile
B.A.D. ETF offers targeted exposure to specific sectors, including betting, alcohol, Canadian cannabis, and pharmaceuticals, through a passive indexing strategy. As a non-diversified fund, it aims to replicate the performance of its underlying index, appealing to investors seeking concentrated exposure to these industries.
What Is the Investment Thesis for BAD?
B.A.D. ETF presents a targeted investment vehicle for those seeking exposure to the betting, alcohol, cannabis, and pharmaceutical sectors. The fund's passive management approach aims to replicate the performance of its underlying index, offering a cost-effective way to invest in these industries. Key value drivers include the growth potential of the cannabis market, the resilience of the alcohol and pharmaceutical sectors, and the expansion of legalized betting and gambling. However, investors should be aware of the risks associated with the fund's non-diversified nature, which makes it susceptible to sector-specific downturns and regulatory changes. The ETF's performance is directly tied to the performance of the companies within its index, making it crucial to monitor the trends and developments within these industries.
Based on FMP financials and quantitative analysis
BAD Key Highlights
- B.A.D. ETF focuses on a niche investment strategy, targeting betting, alcohol, cannabis, and pharmaceutical sectors.
- The fund operates with a passive management approach, aiming to replicate the performance of its underlying index.
- B.A.D. ETF is non-diversified, concentrating its investments in specific sectors, which can lead to higher volatility.
- The fund's performance is directly linked to the growth and regulatory landscape of the betting, alcohol, cannabis, and pharmaceutical industries.
- B.A.D. ETF offers investors a simplified way to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks.
Who Are BAD's Competitors?
BAD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ERM EquityCompass Risk Manager ETF | $23.09 | -0.17% | $8.67M | 44 |
| GERM ETFMG Treatments, Testing and Advancements ETF | $19.16 | -0.29% | $9.59M | 44 |
| GFOF Grayscale Future of Finance ETF | $27.69 | +0.09% | $10.38M | 44 |
| GPOW Goldman Sachs North American Pipelines & Power Equity ETF | $53.96 | -1.00% | $10.49M | 44 |
| HART NYLI Healthy Hearts ETF | $30.67 | +0.32% | $8.66M | 44 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BAD's Key Strengths?
- Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).
- Passive management approach.
- Rules-based index.
- Simplified way to gain exposure to a basket of companies within these sectors.
What Are BAD's Weaknesses?
- Non-diversified nature.
- Susceptibility to sector-specific downturns.
- Reliance on regulatory landscape.
- Potential for high volatility.
What Could Drive BAD Stock Higher?
- Further legalization of cannabis in additional states and countries.
- Expansion of online betting and gambling markets.
- Pharmaceutical companies within the fund achieving FDA approvals for new drugs.
What Are the Key Risks for BAD?
- Regulatory changes negatively impacting the betting, alcohol, cannabis, and pharmaceutical industries.
- Economic downturns reducing consumer spending on these products.
- High volatility due to the fund's non-diversified nature.
- Negative sentiment towards specific sectors affecting investor demand.
What Are the Growth Opportunities for BAD?
- Expansion of Legalized Betting and Gambling: The ongoing legalization of sports betting and online gambling in various jurisdictions presents a significant growth opportunity for B.A.D. ETF. As more states and countries legalize these activities, the companies within the ETF's betting and gambling sector are likely to experience increased revenue and profitability. This trend is expected to continue over the next 3-5 years, driving growth for the ETF. The global online gambling market is projected to reach $127.3 billion by 2027, according to a report by Allied Market Research.
- Growth of the Cannabis Market: The increasing legalization and acceptance of cannabis for both medical and recreational purposes is a major growth driver for B.A.D. ETF. The ETF's exposure to Canadian cannabis companies allows it to capitalize on the expanding cannabis market. As more countries and regions legalize cannabis, the companies within the ETF's portfolio are expected to benefit from increased demand and market opportunities. The global legal cannabis market is projected to reach $90.4 billion by 2026, according to a report by Grand View Research.
- Resilience of the Alcohol Sector: The alcohol industry is known for its resilience, even during economic downturns. B.A.D. ETF's exposure to alcohol companies provides a stable source of revenue and growth potential. The demand for alcoholic beverages remains consistent, making this sector a reliable component of the ETF's portfolio. The global alcoholic beverages market is projected to reach $1.6 trillion by 2025, according to a report by Statista.
- Pharmaceutical Sector Innovation: The pharmaceutical industry is constantly innovating, with new drugs and therapies being developed to address various health conditions. B.A.D. ETF's exposure to pharmaceutical companies allows it to benefit from these advancements. The development and commercialization of new drugs can drive significant revenue growth for the companies within the ETF's portfolio. The global pharmaceutical market is projected to reach $1.57 trillion by 2028, according to a report by Fortune Business Insights.
- Increased Investor Demand for Thematic ETFs: The growing popularity of thematic ETFs, which focus on specific sectors or trends, presents a growth opportunity for B.A.D. ETF. Investors are increasingly seeking targeted exposure to specific areas of the market, and thematic ETFs provide a convenient way to achieve this. As more investors allocate capital to thematic ETFs, B.A.D. ETF is likely to benefit from increased inflows and asset growth. The global thematic ETF market is projected to reach $400 billion by 2027, according to a report by ETFGI.
What Opportunities Does BAD Have?
- Expansion of legalized betting and gambling.
- Growth of the cannabis market.
- Pharmaceutical sector innovation.
- Increased investor demand for thematic ETFs.
What Threats Does BAD Face?
- Regulatory changes in betting, alcohol, cannabis, and pharmaceutical sectors.
- Economic downturns affecting consumer spending on these products.
- Increased competition from other thematic ETFs.
- Negative sentiment towards specific sectors.
What Are BAD's Competitive Advantages?
- First-mover advantage in offering a unique combination of sector exposure.
- Passive management approach provides cost-effectiveness.
- Rules-based index ensures transparency and consistency.
What Does BAD Do?
B.A.D. ETF operates as a passively managed fund, designed to replicate the performance of a specific rules-based index. The fund's investment strategy focuses on providing exposure to a unique combination of sectors: betting or gambling companies, alcohol companies, Canadian cannabis companies (defined as those listed on Canadian exchanges, domiciled in Canada, or primarily operating there), and pharmaceutical companies. By tracking this index, B.A.D. ETF aims to deliver returns that mirror the collective performance of these industries, before accounting for fees and expenses. The fund's non-diversified nature means that its performance is heavily reliant on the performance of these specific sectors, making it a targeted investment vehicle for those with a particular interest in these areas. The fund's structure allows investors to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks, offering a simplified approach to investing in these industries.
What Products and Services Does BAD Offer?
- Tracks a rules-based index focused on betting, alcohol, cannabis, and pharmaceutical companies.
- Provides exposure to a portfolio of companies in specific sectors.
- Offers a passive management approach, aiming to replicate the index's performance.
- Invests in companies listed on Canadian exchanges, domiciled in Canada, or primarily operating in Canada within the cannabis sector.
- Offers investors a simplified way to gain exposure to a basket of companies within these sectors without directly purchasing individual stocks.
- Operates as a non-diversified fund, concentrating its investments in specific sectors.
How Does BAD Make Money?
- Generates revenue through management fees charged to investors.
- Aims to replicate the performance of its underlying index, providing returns to investors.
- Attracts investors seeking targeted exposure to betting, alcohol, cannabis, and pharmaceutical sectors.
What Industry Does BAD Operate In?
B.A.D. ETF operates within the asset management industry, specifically focusing on thematic ETFs that target niche sectors. The ETF's strategy of investing in betting, alcohol, cannabis, and pharmaceutical companies positions it within industries experiencing varying degrees of growth and regulatory scrutiny. The competitive landscape includes other thematic ETFs, such as ERM, GERM, GFOF, GPOW, and HART, that may focus on similar or overlapping sectors. The asset management industry is characterized by increasing demand for specialized investment products, driven by investors seeking targeted exposure to specific market trends and sectors.
Who Are BAD's Key Customers?
- Retail investors seeking exposure to specific sectors.
- Institutional investors looking for targeted investment strategies.
- Investors interested in the betting, alcohol, cannabis, and pharmaceutical industries.
B.A.D. ETF (BAD) Valuation Context
Relative to its peer group, BAD's quantitative score of 44/100 is roughly in line with the peer average of 44/100.
BAD Financials
Bull Case vs Bear Case
Bull Case
- Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals).
- Passive management approach.
- Rules-based index.
- Simplified way to gain exposure to a basket of companies within these sectors.
Bear Case
- Non-diversified nature.
- Susceptibility to sector-specific downturns.
- Reliance on regulatory landscape.
- Potential for high volatility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
BAD Latest News
-
LOAM ENTERTAINMENT'S 'BAD COUNSELORS' ARRIVES IN THEATRES NATIONWIDE JULY 23-27 FROM FATHOM ENTERTAINMENT
prnewswire.com · May 19, 2026
BAD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BAD.
Price Targets
Wall Street price target analysis for BAD.
BAD MoonshotScore
What does this score mean?
The MoonshotScore rates BAD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
What Investors Ask About B.A.D. ETF (BAD) — Financial Services
What does B.A.D. ETF do?
B.A.D. ETF is a passively managed fund that tracks a rules-based index, providing exposure to a portfolio of companies in the betting, alcohol, Canadian cannabis, and pharmaceutical sectors. The fund aims to replicate the performance of its underlying index, offering investors a simplified way to gain exposure to these industries without directly purchasing individual stocks. The ETF's non-diversified nature makes it a targeted investment vehicle for those with a particular interest in these areas, seeking to capitalize on the growth and trends within these specific sectors.
What are the main risks for BAD?
The main risks for B.A.D. ETF stem from its non-diversified nature and its focus on specific sectors. Regulatory changes in the betting, alcohol, cannabis, and pharmaceutical industries could significantly impact the fund's performance. Economic downturns could reduce consumer spending on these products, leading to decreased revenue for the companies within the ETF's portfolio. Additionally, negative sentiment towards specific sectors could affect investor demand and the fund's overall value. These factors highlight the importance of carefully monitoring the trends and developments within these industries.
What are the key factors to evaluate for BAD?
B.A.D. ETF (BAD) holds an AI score of 44/100 (low). Not financial advice.
How frequently does BAD data refresh on this page?
BAD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BAD's recent stock price performance?
B.A.D. ETF (BAD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BAD overvalued or undervalued right now?
Valuing B.A.D. ETF (BAD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying BAD?
Before investing in B.A.D. ETF (BAD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding BAD to a portfolio?
Key strength of B.A.D. ETF (BAD): Unique sector exposure (betting, alcohol, cannabis, pharmaceuticals). Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The fund's performance is heavily reliant on the performance of the specific sectors it targets.
- Regulatory changes in the betting, alcohol, cannabis, and pharmaceutical industries could significantly impact the fund's performance.